AAAAAA
Results:
1-7
|
Results: 7
Authors:
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
Citation: C. Bombardier et al., COX-2 inhibitors and gastrointestinal toxicity, CAN MED A J, 164(8), 2001, pp. 1200-1200
Authors:
Bombardier, C
Laine, L
Reicin, A
Citation: C. Bombardier et al., Upper gastrointestinal toxicity of rofecoxib and naproxen. Reply, N ENG J MED, 344(18), 2001, pp. 1398-1399
Authors:
Konstam, MA
Weir, MR
Reicin, A
Shapiro, D
Sperling, RS
Barr, E
Gertz, BJ
Citation: Ma. Konstam et al., Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib, CIRCULATION, 104(19), 2001, pp. 2280-2288
Authors:
Sperling, R
Braunstein, N
Melin, J
Reicin, A
Citation: R. Sperling et al., Cyclooxygenase 2 inhibitors and thrombogenicity production: Comment on an article by Crofford et al, ARTH RHEUM, 44(5), 2001, pp. 1229-1230
Authors:
Bombardier, C
Laine, L
Reicin, A
Shapiro, D
Burgos-Vargas, R
Davis, B
Day, R
Ferraz, MB
Hawkey, CJ
Hochberg, MC
Kvien, TK
Schnitzer, TJ
Weaver, A
Citation: C. Bombardier et al., Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen inpatients with rheumatoid arthritis., N ENG J MED, 343(21), 2000, pp. 1520-1528
Authors:
Reicin, A
White, R
Weinstein, SF
Finn, AF
Nguyen, H
Peszek, I
Geissler, L
Seidenberg, BC
Citation: A. Reicin et al., Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma, ARCH IN MED, 160(16), 2000, pp. 2481-2488
Authors:
Kalpana, GV
Reicin, A
Cheng, GSW
Sorin, M
Paik, S
Goff, SP
Citation: Gv. Kalpana et al., Isolation and characterization of an oligomerization-negative mutant of HIV-1 integrase, VIROLOGY, 259(2), 1999, pp. 274-285
Risultati:
1-7
|